Clinical Trials Directory

Trials / Unknown

UnknownNCT02556827

Demodex Density, Immune Response and Oxidative Stress in Rosacea Patients

Investigation of Relation Between Demodex Density With Immune Response and Oxidative Stress in Rosacea Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
80 (estimated)
Sponsor
Istanbul Training and Research Hospital · Other Government
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

Aim of study is to determine reactive oxygen products and antioxidant capacity with rosacea patients; to measure metalloproteinase level and inflammatory markers of immune response and investigate their corelation with demodex infestation and also investigate the role of photoaging and sebum secretion in rosacea.

Detailed description

Rosacea is a common and chronic inflammatory disease characterized by facial erythema, papule, pustule and telangiectasia. Ultraviolet, Demodex mite, oxidative stress and antioxidant system disorders are emphasized in increased inflammation seen in rosacea. The aim of our study was to evaluate the status of oxidative stress, matrix metalloproteinase (MMP) and inflammatory markers in systemic circulation, their relationship with demodex density and investigate the role of photoaging and sebum secretion in rosacea. Forty patients with rosacea and age, gender and skin phenotype matched 40 healthy volunteers were enrolled in the study. Reflectance confocal microscopy (RCM) was used to calculate facial demodex density. The number of demodex, follicle, the number of mite per follicle, the number of infested follicle and the number of mite per infested follicle were calculated with RCM. Photoaging severity and facial sebum levels were also assessed. Total oxidant capacity (TOC), total antioxidant capacity (TAC), oxidative stress index (OSI), paraoxonase-1 (PON-1), aryl esterase (ARES), myeloperoxidase (MPO), tumor necrosis factor-alpha (TNF-α), interleukin-1beta (IL-1β), matrix metalloproteinase-1 (MMP-1) and matrix metalloproteinase-9 (MMP-9) levels in venous blood were measured.

Conditions

Interventions

TypeNameDescription
OTHERObtaining a blood sampleTotal oxidant capacity (TOC), total antioxidant capacity (TAC), oxidative stress index (OSI), paraoxonase-1 (PON-1), aryl esterase (ARES), myeloperoxidase (MPO), tumor necrosis factor-alpha (TNF-α), interleukin-1beta (IL-1β), matrix metalloproteinase-1 (MMP-1) and matrix metalloproteinase-9 (MMP-9) levels in venous blood were measured.
DEVICEReflectance confocal microscopy1mm2-sized 10 images were taken from right cheek and forehead; the number of demodex, follicle, the number of mite per follicle, the number of infested follicle and the number of mite per infested follicle were calculated with RCM. And photoaging severity were also assessed by using RCM.
DEVICESebumeterSebum rate at forehead and right cheek were evaluated with sebumeter
DEVICEVideo dermoscopyDermoscopic photoaging scale were assessed by using video dermoscopy.

Timeline

Start date
2015-07-01
Primary completion
2015-11-01
Completion
2015-12-01
First posted
2015-09-22
Last updated
2015-09-23

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT02556827. Inclusion in this directory is not an endorsement.

Demodex Density, Immune Response and Oxidative Stress in Rosacea Patients (NCT02556827) · Clinical Trials Directory